197240-27-0

Basic information

• Product Name: 2-Hydroxy-1-[4-(methylsulphonyl)phenyl]ethan-1-one
• Synonyms: 2-Hydroxy-1-[4-(methylsulphonyl)phenyl]ethan-1-one;2-Hydroxy-4'-(methylsulphonyl)acetophenone;2-Hydroxy-1-(4-(Methylsulfonyl)phenyl)ethanone
• CAS NO: 197240-27-0
• Molecular Formula: C₉H₁₀O₄S
• Molecular Weight: 214
• Mol File: 197240-27-0.mol

Chemical Properties

• Melting Point: 136～138℃
• Appearance: /
• CAS DataBase Reference: 2-Hydroxy-1-[4-(methylsulphonyl)phenyl]ethan-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Hydroxy-1-[4-(methylsulphonyl)phenyl]ethan-1-one(197240-27-0)
• EPA Substance Registry System: 2-Hydroxy-1-[4-(methylsulphonyl)phenyl]ethan-1-one(197240-27-0)

Safety Data

• Hazardous Substances Data: 197240-27-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-Hydroxy-1-[4-(methylsulphonyl)phenyl]ethan-1-one is used as an anti-inflammatory and anti-cancer agent for its ability to inhibit the growth of cancer cells and reduce inflammation in various conditions, such as arthritis and inflammatory bowel disease.
Used in Cancer Treatment:
2-Hydroxy-1-[4-(methylsulphonyl)phenyl]ethan-1-one is used as a potential therapeutic agent for the treatment of various types of cancer due to its ability to inhibit the growth of cancer cells.
Used in Inflammatory Conditions Treatment:
2-Hydroxy-1-[4-(methylsulphonyl)phenyl]ethan-1-one is used as a treatment for various inflammatory conditions, such as arthritis and inflammatory bowel disease, due to its ability to reduce inflammation.

Upstream product

• 50413-24-6 2-bromo-1-(4-methanesulfonylphenyl)ethanone 
• 10297-73-1 4-(methanesulfonyl)acetophenone 

Downstream Products

• 204389-59-3 phenyl-carbamic acid 2-(4-methanesulfonyl-phenyl)-2-oxo-ethyl ester 
• 204389-65-1 p-tolyl-carbamic acid 2-(4-methanesulfonyl-phenyl)-2-oxo-ethyl ester 
• 197240-22-5 2-(4-methanesulfonylphenyl)-2-oxo-ethyl 4-fluorophenyl-carbamate 
• 204389-67-3 (4-trifluoromethyl-phenyl)-carbamic acid 2-(4-methanesulfonyl-phenyl)-2-oxo-ethyl ester 
• 855309-65-8 C₃₀H₁₉NO₈S₂ 

Relevant articles and documents

Spiro[indene-1,4′-oxa-zolidinones] Synthesis via Rh(III)-Catalyzed Coupling of 4-Phenyl-1,3-oxazol-2(3 H)-ones with Alkynes: A Redox-Neutral Approach

Transition-metal-catalyzed C-H activation synthesis of heterocyclic spiro[4,4]nonanes has persistently witnessed the use of additional stoichiometric transition-metal oxidant when employing C=C bond as the spiro ring closure site. Herein, we have addressed the issue by reporting a redox-neutral strategy for spiro[indene-1,4′-oxa-zolidinones] synthesis via Rh(III)-catalyzed coupling of 4-phenyl-1,3-oxazol-2(3H)-ones with alkynes. The synthesis features a broad substrate scope and high regiospecificity.

OPTICAL IMAGING CONTRAST AGENTS FOR IMAGING LUNG CANCER

The invention provides contrast agents for optical imaging of lung cancer in patients. The contrast agents may be used in diagnosis of lung cancer, for follow up of progress in disease development, for follow up of treatment of lung cancer and for surgica

OPTICAL IMAGING CONTRAST AGENTS FOR IMAGING LUNG CANCER

The invention provides contrast agents for optical imaging of prostate cancer in patients. The contrast agents may be used in diagnosis of prostate cancer, for follow up of progress in disease development, for follow up of treatment of prostate cancer and

Synthesis and biological evaluation of 3,4-diaryloxazolones: A new class of orally active cyclooxygenase-2 inhibitors

A series of 3,4-diaryloxazolones were prepared and evaluated for their ability to inhibit cyclooxygenase-2 (COX-2). Extensive structure-activity relationship work was carried out within this series, and a number of potent and selective COX-2 inhibitors we